ALGN - Align Technology Inc

ALGN

$143.13 +2.71 (+1.93%) Last updated: Oct 13, 2026 19:54

52-Week Range

$143.13

$126.33 $143.13 $200.44

Fundamentals Overview

Align Technology Inc is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 24.6 PEG 2.88 P/B 2.85 P/S 2.46

Profitability

ROE 10.09% Net margin 10%

Risk (Beta)

1.74 — higher vol

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Sell — 66% confidence Risk: High Volatility — Beta 1.74. Consider smaller position size due to higher beta.

Pressures (Sell):

PEG 2.88 · Beta 1.74 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$9.98B

P/E (TTM)

24.6

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$126.33 - $200.44

Volume vs Avg

0.77x

77% of avg (Below)

Beta

1.74

About

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 mill...

Sector: Healthcare

Headquarters: US

Website: www.aligntech.com

Beta: 1.74 (More volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	24.6
PEG (TTM)	2.88
P/B (TTM)	2.85
P/S (TTM)	2.46
Profitability
ROE (TTM)	10.09%
ROA (TTM)	6.56%
Revenue growth (YoY)	N/A
Net margin (TTM)	9.99%
Gross margin (TTM)	69.05%
Operating margin (TTM)	13.23%
Debt to equity (TTM)	0

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ALGN.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.